 Shares of Cantel Medical NYSE:CMD were flat in pre-market trading after the company reported Q3 results.Quarterly Results Earnings per share decreased 70.91 over the past year to 0.16, which missed the estimate of 0.37.Revenue of 236,933,000 rose by 3.67 from the same period last year, which missed the estimate of 242,630,000.Outlook Earnings guidance hasnt been issued by the company for now.Revenue guidance hasnt been issued by the company for now.Details Of The Call Date: Jun 04, 2020View more earnings on CMDTime: 08:30 AMET Webcast URL: 52-week high: 93.8752-week low: 20.81Price action over last quarter: down 16.65Company Overview Cantel Medical is a New Jersey-based manufacturer of hospital supplies for infection prevention, which include products used in endoscope disinfection, water purification systems for use in dialysis treatment, and dental supplies. The firm reports in four segments: medical 57 of fiscal 2019 sales, life sciences 22, dental 18, and dialysis 4. Geographic exposure is primarily in the U.S., which accounts for 75 of revenue, with international markets making up the remaining 25.See more from Benzinga SecureWorks: Q1 Earnings Insights Recap: Kirklands Q1 Earnings Recap: Destination XL Group Q1 EarningsC 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. 